4//SEC Filing
Piekos Brian 4
Accession 0000899243-21-019763
CIK 0001816736other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:45 PM ET
Size
5.0 KB
Accession
0000899243-21-019763
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-05-14$9.46/sh+7,655$72,432→ 7,655 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $9.30 to $9.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Gemini Therapeutics, Inc. /DE
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001815308
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:45 PM ET
- Size
- 5.0 KB